본문바로가기 주메뉴바로가기 홈페이지정보바로가기

BHS한서병원

대표전화:1666-8275
진료과바로가기
  • home
  • 로그인
  • 회원가입
  • 사이트맵

센터안내

  • 전문센터
  • 진료과
  • 증명서발급

BHS한서병원에서 운영되고 있는 전문센터에서 최고의 치료를 제공해 드리겠습니다.

전문센터를 선택해 주십시오
  • BHS CENTER
  • 내시경센터
  • 헬스케어센터
  • 척추센터
  • 심장혈관센터
  • 응급의료센터
  • 재활치료센터
  • 감상선/유방센터
  • 신장센터
  • 관절센터
  • 뇌신경센터
대표전화:1666-8275, 051) 756-0081 / 예약전화:051) 750-1181,070-7321-0061 / 응급의료센터:070-7321-0118, 0119

약도인쇄

예약확인

신장센터

BHS센터안내신장센터

  • 센터소개
  • 해외학회
  • Q&A
  • 신장이식 활성화
  • 인공신장센터
  • 사구체신장염
  • 당뇨신증
  • 신장질환
  • FAQ
2017
2017.05 대한신장학회, 서울 Continuous renal replacement therapy as a treatment for severe acute hypernatremia induced by central diabetes insipidus.
2017.09 유럽이식학회 (ESOT; European Society of Organ Transplantation), Barcelona, Spain.
Anti-HLA antibody-mediated rejection in ABO-incompatible living donor kidney transplant patients.
2017.10 대한이식학회 (Asian Transplant Week), 인천 Induction therapy in kidney transplant patients.
2017.11 미국신장학회 (Annual Meeting of American Society of Nephrology), New Orleans, USA.
Sodium/Glucose Cotransporter 2 Inhibitor for the treatment of diabetes in kidney transplant patients.
2016
2016.05 유럽신장학회 (EDTA; Annual Meeting of European Dialysis and Transplantation Association), Vienna, Austria.
Anti-HLA antibody-induced rejection in ABO-incompatible living donor kidney transplant patients.
2016.06 대한신장학회, 서울 ABO-incompatible living donor kidney transplantation: An update.
2016.08 세계이식학회 (International Congress of The Transplantation Society), Hong Kong.
Sodium/Glucose Cotransporter 2 Inhibitor for the treatment of diabetes in kidney transplant patients.
Anti-HLA antibody-induced rejection in ABO-incompatible living donor kidney transplant patients.
2015
2015.05 대한신장학회, 서울 Prevalence and associated clinical features of donor specific anti-HLA antibody(DSA) of renal allograft recipients in late posttransplant period.
2015.05 유럽신장학회 (EDTA; Annual Meeting of European Dialysis and Transplantation Association), London, U.K. Rituximab for the treatment of posttransplant donor specific anti­HLA antibody.
2015.08 아시아 이식학회 (Congress of the Asian Society of Transplantation), Singapore.
High- versus Low-titer anti-ABO antibody in ABO incompatible living donor kidney transplantation.
Rituximab for the treatment of posttransplant donor specific anti­HLA antibody.
2015.09 유럽이식학회 (ESOT; European Society of Organ Transplantation), Brussels, Belgium.
Living donor kidney transplantation from HBsAg(+) donor to HBsAg(-) recipient with or without anti-HBs
2014
2014.04 유럽신장학회 (EDTA; Annual Meeting of European Dialysis and Transplantation Association), Amsterdam, Netherland.
Living donor kidney transplantation from HBsAg(+) donor to HBsAg(-) recipient with or without anti-HBs.
2014.06 미국이식학회 (American Transplant Congress),
세계이식학회 (International Congress of The Transplantation Society), San Francisco. USA.
Living donor kidney transplantation from HBsAg(+) donor to HBsAg(-) recipient with or without anti-HBs.
2013
2013.05 유럽신장학회 (EDTA; Annual Meeting of European Dialysis and Transplantation Association), Amsterdam, Netherland.
Living donor kidney transplantation from HBsAg(+) donor to HBsAg(-) recipient with or without anti-HBs.
High- versus Low-titer anti-ABO antibody in ABO incompatible living donor kidney transplantation.
2013.05 세계신장학회 (World Congress of Nephrology), Hong Kong ABO-incompatible living donor kidney transplantation with minimal dose of rituximab.
2013.11 국제 이종 이식학회 (IXA; Congress of International Xenotransplantation Association), Osaka, Japan.ABO-incompatible living donor kidney transplantation in Korea.

quickmenu

의료진소개

진료시간

찾아오시는길

입퇴원안내

진료예약

진료상담

신장센터 Q&A

고객의소리

본문맨처음으로가기